Article thumbnail

WWOX expression in colorectal cancer—a real-time quantitative RT-PCR study

By Maciej Jakub Żelazowski, Elżbieta Płuciennik, Grażyna Pasz-Walczak, Piotr Potemski, Radzisław Kordek and Andrzej Kazimierz Bednarek


The WWOX gene is a tumour suppressor gene affected in various types of malignancies. Numerous studies showed either loss or reduction of the WWOX expression in variety of tumours, including breast, ovary, liver, stomach and pancreas. Recent study demonstrated that breast cancer patients exhibiting higher WWOX expression showed significantly longer disease-free survival in contrast to the group with lower relative WWOX level. This work was undertaken to show whether similar phenomena take place in colon tumours and cell lines. To assess the correlation of WWOX gene expression with prognosis and cancer recurrence in 99 colorectal cancer patients, we performed qRT-PCR analysis. We also performed analysis of WWOX promoter methylation status using MethylScreen method and analysis of loss of heterozygosity (LOH) status at two WWOX-related loci, previously shown to be frequently deleted in various types of tumours. A significantly better disease-free survival was observed among patients with tumours exhibiting high level of WWOX (hazard ratio = 0.39; p = 0.0452; Mantel–Cox log-rank test), but in multivariate analysis it was not an independent prognostic factor. We also found that although in colorectal cancer WWOX expression varies among patients and correlates with DFS, the exact mode of decrease in this type of tumour was not found. We failed to find the evidence of LOH in WWOX region, or hypermethylation in promoter regions of this gene. Although we provide the evidence for tumour-suppressive role of WWOX gene expression in colon, we were unable to identify the molecular mechanism responsible for this

Topics: Research Article
Publisher: Springer Netherlands
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2011). a novel WW domain-containing protein mapping to 558 Tumor Biol.
  2. (2006). A role for the WWOX gene in prostate cancer. Cancer Res.
  3. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
  4. Al Attiyah R. c-myc antisense oligonucleotides sensitize human colorectal cancer cells to chemotherapeutic drugs.
  5. (2011). CDH1 gene polymorphisms, smoking, Helicobacter pylori Tumor Biol.
  6. Cyclin E as a prognostic and predictive marker in breast cancer.
  7. (1996). Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region. Cancer Res.
  8. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
  9. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
  10. (2011). Fragile histidine triad protein, WW domaincontaining oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.
  11. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res.
  12. (2008). Homozygous deletions may be markers of nearby heterozygous mutations: the complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX. Genes Chromosom Cancer.
  13. Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
  14. (2007). Inhibition of breast cancer cell growth in vitro and in vivo: effect of restoration of Wwox expression. Clin Cancer Res.
  15. Inhibition of the Wnt/beta-catenin pathway by the WWOX tumor suppressor protein.
  16. (1997). Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosom Cancer.
  17. (2004). Loss of WWOX expression in gastric carcinoma. Clin Cancer Res.
  18. MethylScreen: DNA methylation density monitoring using quantitative PCR.
  19. Modest promoter methylation of E-cadherin gene in sporadic colorectal cancers: a quantitative analysis.
  20. Molecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiforme.
  21. (1999). Mutated epithelial cadherin is associated with increased tumorigenicity and loss of adhesion and of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc Natl Acad Sci USA.
  22. (2007). Prognostic value of CpG island hypermethylation at PTGS2, RAR-beta, EDNRB, and other gene loci in patients undergoing radical prostatectomy. Eur Urol.
  23. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer.
  24. (2007). Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci USA.
  25. (2008). The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci.
  26. the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res.
  27. The methodology used to measure differential gene expression affects the outcome.
  28. The NRIF3 family of transcriptional coregulators induces rapid and profound apoptosis in breast cancer cells.
  29. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res.
  30. The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism.
  31. (2003). WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res.
  32. (2005). WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res.
  33. (2007). WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res.
  34. (2010). WWOX gene and gene product: tumor suppression through specific protein interactions. Future Oncol.
  35. WWOX in biological control and tumorigenesis.
  36. WWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcome.
  37. WWOX–the FRA16D cancer gene: expression correlation with breast cancer progression and prognosis.
  38. WWOX: a candidate tumor suppressor gene involved in multiple tumor types.
  39. (2004). X-tile: a new bioinformatics tool for biomarker assessment and outcome-based cutpoint optimization. Clin Cancer Res.